To further evaluate risk to non-tumor cells, we performed cytotoxicity experiments using primary mouse fibroblasts (exposed to MHC-replete tumor cells to simulate the tumor environment) and observed these cells to be significantly less susceptible to killing than MHC-I-negative tumor cells placed under the same conditions (Extended Data Fig. 5h). The gene discussed is HLA-C; the disease is neoplasm.